Pharma channel feed – Endpoints News

Pharma channel feed

Telehealth startup Done's execs arrested and charged for alleged Adderall scheme, DOJ says

11 months ago

Alchem faces fines over price-fixing allegation from the European Commission

11 months ago

Only a third of employers and health plans cover GLP-1 drugs for weight loss, report says

11 months ago

Gilead's M&A appetite is for deals in the 'mid-single-digit billions,' CEO says

11 months ago

Lilly, Eisai and Biogen seek more specifics in FDA guidance on early Alzheimer’s disease

11 months ago

States join Oklahoma effort to convince Supreme Court to let them regulate PBMs

11 months ago

Pfizer strikes an R&D partnership with Flagship's ProFound as it looks for next-gen obesity assets

11 months ago

J&J agrees to $700M talc settlement with 42 states and DC

11 months ago

Updated: FDA funding would stay flat under House appropriations bill

12 months ago

Lilly exec points to Medicare as more pay full list price for Zepbound than Mounjaro

12 months ago

NJ federal judge rules Teva inhaler patents are 'improperly listed' in Orange Book

12 months ago

Sanders pushes subpoena vote to force testimony of Novo Nordisk exec on GLP-1 prices

12 months ago

Verily gets into the GLP-1 business with new program to manage cardiac and metabolic conditions

12 months ago

Ipsen and Genfit secure FDA thumbs up for rare liver disease asset

12 months ago

FDA advisors back Lilly’s Alzheimer’s drug, setting stage for approval after delay

12 months ago

Paxlovid did not beat placebo in Stanford-led long Covid study

12 months ago

FDA establishes new meeting type to advise on drug safety technology

12 months ago

EU launches two advice pilots for clinical trial applications as part of R&D push

12 months ago

GSK wins expanded FDA approval for RSV shot in at-risk adults ages 50 to 59

12 months ago

Federal judge dismisses antitrust claims brought against Bristol Myers by insurers

12 months ago

FDA greenlights Geron’s imetelstat to treat anemia in certain cancer patients

12 months ago

Italian antitrust agency investigates Novartis, Biogen and others over Lucentis biosimilar

12 months ago

Senate fails to pass bill codifying access to contraception

Last year

FDA explains why it rejected Vanda's insomnia application as company faces takeover bid

Last year

First page Previous page 51 52 535455 56 57 Next page Last page